We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

106 hedge funds and large institutions have $368M invested in GenMark Diagnostics, Inc in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 28

42% more capital invested

Capital invested by funds: $259M → $368M (+$110M)

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

3% more funds holding

Funds holding: 103106 (+3)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $74K

Holders
106
Holders Change
+3
Holders Change %
+2.91%
% of All Funds
2.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
41
Reduced
28
Closed
11
Calls
Puts
$74K
Net Calls
-$74K
Net Calls Change
-$15K
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$2.04M +$707K +107,295 +59%
Deutsche Bank
27
Deutsche Bank
Germany
$2M +$573K +87,069 +45%
NIM
28
Needham Investment Management
New York
$1.71M -$263K -40,000 -14%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.7M +$43.2K +6,562 +3%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$1.54M +$477K +72,500 +50%
Federated Hermes
31
Federated Hermes
Pennsylvania
$1.42M
TCIM
32
TIAA CREF Investment Management
New York
$1.3M +$187K +28,400 +18%
GIP
33
Granite Investment Partners
California
$1.24M +$250K +37,926 +28%
SSA
34
Schonfeld Strategic Advisors
New York
$1.19M +$115K +17,400 +12%
Russell Investments Group
35
Russell Investments Group
United Kingdom
$1.18M -$278K -42,140 -20%
TA
36
Teachers Advisors
New York
$1.1M +$202K +30,659 +25%
TD Asset Management
37
TD Asset Management
Ontario, Canada
$1.08M -$36.2K -5,500 -3%
Man Group
38
Man Group
United Kingdom
$1.02M +$946K +143,700 New
Renaissance Technologies
39
Renaissance Technologies
New York
$937K +$870K +132,135 New
WMSA
40
Weiss Multi-Strategy Advisers
New York
$922K -$3.46K -526 -0.4%
Wells Fargo
41
Wells Fargo
California
$713K +$358K +54,341 +117%
Swiss National Bank
42
Swiss National Bank
Switzerland
$686K +$20.4K +3,100 +3%
William Blair & Company
43
William Blair & Company
Illinois
$661K
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$638K -$13.2K -2,000 -2%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$563K +$329 +50 +0.1%
RA
46
Royce & Associates
New York
$540K
ARTA
47
A.R.T. Advisors
New York
$460K +$427K +64,911 New
DCM
48
Donaldson Capital Management
Indiana
$447K
AllianceBernstein
49
AllianceBernstein
Tennessee
$428K +$29.6K +4,500 +8%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$404K +$55.4K +8,418 +17%

GNMK Hedge Fund Activity: Q1 2019 in Review

106 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2019, worth a combined $368M — up 42% from $259M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new GNMK positions and 11 closed out — a net gain of 3 holders — while 41 added to existing stakes and 28 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.76M. The largest seller was JP Morgan Chase, cutting an estimated $9.69M.

  • 106 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2019, up from 103 in Q4 2018.
  • Funds reported $368M of GenMark Diagnostics, Inc stock for Q1 2019, up 42% quarter-over-quarter.
  • 14 funds opened new GenMark Diagnostics, Inc positions in Q1 2019 and 11 closed out, a net change of +3 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q1 2019 was Millennium Management, an estimated $2.76M added.
  • The largest GenMark Diagnostics, Inc seller in Q1 2019 was JP Morgan Chase, an estimated $9.69M sold.

Based on aggregated 13F filings for Q1 2019.